Another co-expressed gene, NUSAP1, is also recognized as an independent risk factor for HCC patient outcome, and regulates the expression of CDK4, CDK6, and cyclinD1, which participate in cell cycle progression [29]. The gene discussed is CDK4; the disease is hepatocellular carcinoma.